Please ensure Javascript is enabled for purposes of website accessibility
Home / Information / References

Design and structural optimization of orally bioavailable SOS1 inhibitors for the treatment of KRAS-driven carcinoma
2024-10-09 44

Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only